A. EKİN Et Al. , "The Retrospective Evaluation of Efficacy and Safety Data after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) in Patients Diagnosed with Systemic Lupus Erythematosus: A Single-Center Experience," EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.28, no.10, pp.3513-3522, 2024
EKİN, A. Et Al. 2024. The Retrospective Evaluation of Efficacy and Safety Data after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) in Patients Diagnosed with Systemic Lupus Erythematosus: A Single-Center Experience. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.28, no.10 , 3513-3522.
EKİN, A., MISIRCI, S., COŞKUN, B. N., YAĞIZ, B., DALKILIÇ, H. E., & PEHLİVAN, Y., (2024). The Retrospective Evaluation of Efficacy and Safety Data after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) in Patients Diagnosed with Systemic Lupus Erythematosus: A Single-Center Experience. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.28, no.10, 3513-3522.
EKİN, Ali Et Al. "The Retrospective Evaluation of Efficacy and Safety Data after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) in Patients Diagnosed with Systemic Lupus Erythematosus: A Single-Center Experience," EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.28, no.10, 3513-3522, 2024
EKİN, Ali Et Al. "The Retrospective Evaluation of Efficacy and Safety Data after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) in Patients Diagnosed with Systemic Lupus Erythematosus: A Single-Center Experience." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.28, no.10, pp.3513-3522, 2024
EKİN, A. Et Al. (2024) . "The Retrospective Evaluation of Efficacy and Safety Data after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) in Patients Diagnosed with Systemic Lupus Erythematosus: A Single-Center Experience." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.28, no.10, pp.3513-3522.
@article{article, author={Ali Ekin Et Al. }, title={The Retrospective Evaluation of Efficacy and Safety Data after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) in Patients Diagnosed with Systemic Lupus Erythematosus: A Single-Center Experience}, journal={EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES}, year=2024, pages={3513-3522} }